Latest Low-density lipoprotein Stories
International research effort results in first pharmaceutical agent developed for homozygous familial hypercholesterolemia An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a rare and deadly cholesterol disorder. Penn researchers report in The Lancet that lomitapide, a first-in-class microsomal triglyceride transfer...
Connie K. Ho for redOrbit.com – Your Universe Online A new study from the University of Copenhagen recently revealed that high blood cholesterol is a serious hereditary disease that has been overlooked and has not been given effective treatments as compared to other illnesses. In particular, the scientists discovered that there are more Danes who have high blood cholesterol than previously thought. They believe that few individuals and families with the disease have been identified;...
MAPLE GROVE, Minn., Nov. 1, 2012 /PRNewswire/ -- When searching the pharmacy shelves, people looking for help to support healthy good cholesterol with a dietary supplement niacin may inaccurately associate the ingredient nicotinic acid with smoking cessation because it sounds like nicotine, warns leading cardiologist, Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA. In fact, nicotinic acid is...
PARIS and TARRYTOWN, N.Y., Oct. 31, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that results from a Phase 2 trial of SAR236553/REGN727 in patients with primary hypercholesterolemia were published in the October 31, 2012 issue of the New England Journal of Medicine. The study enrolled patients with primary hypercholesterolemia with elevated LDL-C (greater than or equal to 100 mg/dL) who were on a...
redOrbit Staff & Wire Reports - Your Universe Online In a discovery that could help prevent and treat heart disease, a team of Canadian researchers say that they have found a protein that can increase the production of low-density lipoprotein (LDL) cholesterol. The scientists, who presented their findings Sunday at the Canadian Cardiovascular Congress in Toronto, said that resistin, which is secreted by fatty tissue, causes human liver cells to produce more LDL, known as the "bad"...
FRAMINGHAM, Mass., Oct. 22, 2012 /PRNewswire/ -- MassEcon has named Boston Heart Diagnostics (BHD) as a "Rising Star" winner for the Team Massachusetts Economic Impact Awards. The annual award celebrates companies that have made outstanding contributions to the Massachusetts economy. Boston Heart Diagnostics and the other winners will be recognized at a November 20(th) awards luncheon with featured speaker Governor Deval Patrick. More than 400 attendees are expected at the event,...
Peter Suciu for redOrbit.com – Your Universe Online There is often discussion about good cholesterol versus bad cholesterol, but now the bad cholesterol levels in American adults could be falling and that is certainly good news. A new government study released on Tuesday reported that cholesterol levels have significantly improved over the past 20 years. The causes are likely from a decrease in the intake of trans-fats in diets, as well as the use of cholesterol-lowering drugs. The...
Connie K. Ho for redOrbit.com – Your Universe Online Researchers at Oregon State University (OSU) recently conducted a comprehensive review and discovered that higher-dose use of particular statins can help treat high cholesterol and other blood lipid problems. In particular, the researchers believe that medications should be considered as an option after patients have tried to manage cholesterol issues with changes in diet and exercise. According to the review’s findings, some...
CHOP Scientist's Gene Chip Used to Expand List of Possible Drug Targets to Lower Lipid-Related Health Risks PHILADELPHIA, Oct. 11, 2012 /PRNewswire-USNewswire/ -- In the largest-ever genetic study of cholesterol and other blood lipids, an international consortium has identified 21 new gene variants associated with risks of heart disease and metabolic disorders. The findings expand the list of potential targets for drugs and other treatments for lipid-related cardiovascular disease,...
Benefit6 Whole Body Protection contains key ingredients providing maximum antioxidant protection. Rancho Palos Verdes, CA (PRWEB) October 02, 2012 Benefit6 and new dietary supplements reduces inflammation while providing protective antioxidant support. Maintaining a healthy inflammatory system is vital. Reducing chronic inflammation can provide a wide range of health benefits, including heart and joint support while antioxidants play an important role in fighting cellular damage caused...
